| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | 0.093 | 0.01 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.084 | 0.01 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.094 | 0.01 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.091 | 0.01 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.01 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.01 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.02 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | 0.08 | 0.02 |